lsHITA DRUGS & INDUSTRIES LTD.Corp. Off.: 401, 3rd Eye 11, Opp. Parimal Garden, C. G. Road, Ahmedabad-380006,Phone : +919228016100 -03 I +9179 2646 8353. 4002 3839 I Fax : +9179 26404961

E.e£:;,3#oC&jsfi.aFdar:tes°.::in:,'7:{j'idvrausgnsaa(::i.'neTta'.,Sana:d:£.js:hffahdT:gds:cboa:.

Date: 29th May, 2018

To,The Company SectionThe Bombay Stock ExchangePhiroz Jijibhoy TowersDalal Street,Bombay-400 001

Dear Sir,

g±[g±LfflE±±quLODI`)..±±ng!nggL2q£±:3!!Ei£::;E§E3Ei3§§£fffi:8E§fi5!¥ffbEfa]L.2°18Dursuant!QLB±grd2flgE

tTd[:yjsoi°j::°edTyy2*h#yh,e2E:a:£fAd;rpercot::S£:*:d:£¥PF¥nyanactfitsR:::i:::fh#:Companyofthequarterandyearendedon31stMarch,2018.

Pursuant to Regulation 33 of SEBI a.isting Otiligation and Disclosure Requirements)Regulations, 2015, we hereby enclose the following:-

1. Approved the Audited Financial Results of the Quarter and Year ended 31stMarch, 201 8

2. Auditors Reports on Audited Financial Results3. Declaration regarding unmodified audit report along with Form "A"

The aforesaid is for kind information and doing the needful in the matter

Hope the enclosed papers are in accordance with requirements.

Please acknowledge receipt

Thanking You.

"Our basic d:rags in the serirtce Of ho:manly `uortifrdeD

CIN No. L24231 GJ1992PLC017054D & 8 D-u-N-S Number -65-0180359

cO+

ato

J>r®

0®

cO+

0\u

D

EF5

aC

La

aa,

t®

Ig

II

I

i

iB`F3FgB

iiBi`iIii==E®8a®I.=:

Eg;i?ai89iga9`E

:EPii

E!i§9`i.ia,ii?E.f.

ai8!iiE'B?

FIll#e`i8.

iaBiaB'gi

aiai`iiii:aI.

BZiiB6aaai

EFrtl

iFaF

FtTI5 :5gE]

diB

:iiBE'iiF

:Brr'EC,9.BiitTl5

i?•F8Brr'5

?8='i9`IE?iiii9`i

a9'ii

iaI

iB!i

9eIe8

9e+ae

0ee8

.aa.e®

+e8

?6!?a

+t®

I

!eaaa

8Ch+®un

•cOt5!

8at^

=®=

I

B0cO

t=y,cO

®iae

i®ii

?a8

•;.08

a8a8

a8y\a

ae.e8

ae.0a

a08

8is

0080

?g8a

L®viu

ua?S

:a=J>

®ii

i !!

9`=a8

aae

ae?8

a8a±

c>'8.®a

aA8

•Se'8

eato==

£cOa

ua.58

ua®vi'8

=8:•!

tJ,aI++a

®i+BEii

.ii.

Sa;ae

aa;e8

.e§a-8

0'8.Eai

aag

eaeo+

•Sa'8

•ga

?a!®0\

R€®®

N+®~

a=a!fo

a%8

0i iE!!

i

ga8

•§a8

aeae

'a85

ai•;

et^qc8

Saa8

!§J>t

hW€

DaS+

I,=t^=

uaS8:•;

NS§=

®i+

i

cfu

c2ir±

aB8!Eai8!;.

E

aiE=

SB

=:

e=

=hJ

t®t®

t®8

®

iE'

Ig9Ei?

EgEB

BBBE

.E

BI,i.ii

EB9.9.

iigiF¥i

iiiigi9,=Ig9E

i.i'!igg9`E. Bg

i.9`tl)i.CAI, !I

9i5.Eii

:B9a53aa

:i3a

i?E.ii €

9..g

gi`

8igi8g

gi

Z!gge. ?ie

giii8

¥i:eai

iiia,

gaEaE

!9E`gi.?

iIa,i?aBi

ei.?ai.

i5i

=.5ie`

i.8

i8.

9.ii.

i.9.

i:i.

iii

i:

!!

E.ii8`iiai.

i8'ia;.

aE.aB

' 9.iaiie`E

EF5Ei9`B

i9i'

aa

ae

ee

ea

ae

0a

ae

Se

aa

0

®i

i®iE

•iE8

'88

€8

'8'8

t®®t®®

'88

8a

-8a

8§

88

N~

t,Ii

€

®IE!it

J>a+i!

i i

j!i8e

i i.ia

.cOi

I3ea'8

aea8

.e8e'8

e'8a8

a8?8

eae8

e`8e8

®aa8

a8ae

0e+

=€

cOS:

C®t®

®iii:

a0

ea

.ae

e0

a.a

9?

ee

~€a

aa

a

®i+

iE§

B.

88

8~

t®a

8~

t®a

88

8a

a8

e8

8

F``

`I-.Ir-a

ae

00

0a

0e

ea

aa

aa

~€a

ae

a

®i

iig!?F

B59`aBBB

a'8

'8a

ae

SC

Oa

'8e

'8'8

`8a

8`8

8e

5'EgB

0a

ee

00

ae

ea

ea

0a

t®€0

ae

e

t~i+

i8!

`8a

'8a

a`8

eC

r\a

88

ea

8S

`8'8

8'8

!!9

r--=

=`- I

c9A

- C

21

PtryRE

lsIllTA DRUGS AND INDuSTRIES LIMITED

CIN : L24231GJ1992PLcO17054/ Registered office: Survey No.179/1, Vlllage : V

asma-Iyava, Ta. SanandAhmedabad - 382170

Website: `^r`Af`^/.ishftadrugs.comConcoct: col 92Z8016100

Statement of Assets and liabilities

Partloulars

Year Eitded Previous Year Ended12 Months Ended 12 Months Ended

Audited Audited31-Mar-18 31-Mal.-17

ASSETS

1 Nori-current assetsProperty, plant and equipment 11879886 10171144Capital work-in-progressInvestment propertyGoodwill

Other intangible assetsIntangible assets under development

Biological assets other than bearer plantsInvestments accounted for using equity method

Non{urreut financial assets 11879886 10171144Non-current investments 1592254 1592254Trade receivables, non-current

Loans, nan-current 498200 498200Other non-current financial assets

Total Nan-currrent financial assets Z090454 2090454Deferred tax assets (net)Other non-current assets

Total Non{Lirrent Assets 13970340 122615982 Currei`t assets

Inventories 7200886 5616304Current financial assets

Current investments 29936585 25361292Trade receivables, current 8215528 17040975Cash and cash equivalents 251974 1174114Bank balance other than cash and cash equivalent 6500088 3051072Loans, current 736491 89175Other current financial assets 5377578 7050239

Total cLirrent firiancfal assets 51018244 53766867Current tax assets (net)Other current assets

Total Current Assets3 Non-current assets classified as held for sale

4 F`egulatory deferral account debit balances andrelated deferred tax Assets

TOTAL ASSETS 72189470 71644769

EQulTIES AND llABILITIES

1 Eql'ity+iEqufty attrlbutable to owners of Parent

Equity share capital 29903000 29903000Other equity 30720893 28242900

Total Equlty attrlbiltable to oumers Of Parent 60623893 58145900Non controlling interest

Total Equity 60623893 581459002 Liab"lties

Nan-current liabilitiesNon{urrent financial llabllItles

Borrowing, nan-current 849413Trade payables, non-currentOther non-current financial liabilities

Total Norwurrent financial llab!Iitles 849413Provisions, nan-current

Deferred tax liabilities (net) 593317 639428Deferred government grants, Non-current othernon-current liabilities

Total Non{urrent liabllltles 593317 639428Current liabllit!esCurrent flnanclal Iiabllltles

Borrowing, current 417537 72229Trade payables, current 5616188 11816720Other current financial liabilities

Total current financlal llabilities 6033725.00 11888949.00Other current liabilities 2932592 61652Provisions, current 1156530 908840Current tax liabilities (Net)

Deferred government grants, CurrentTotal cLirreut llablllties 408912Z 970492

3Liabilities directly associated with assets in disposal

group classified as held for sale

4Regulatory deferral account credit balances and

related deferred tax liability

Total Llal)ll]tlesTotal Equfty and tjabilities 72189470 71644769

For, IsllITA DRUGS AND INDUSTRIES LIMITED

JAGDISH AGRAWALPlace Ahmedabad MANAGING DIRECTOR

Date 29-May-18 DIN: 01031687

PRATIK RAUSHII(KUMAR I(lKANlCHARTE RED ACCOU NTANTS-i.ri.` -Ll`[v Alluulv I All I > PAN -ATVPK1876E";i,-,i:=f::..-::-.-=-_._i-.._.:..i_`:-I_i::_I-"i-.F=F==.¥=.'T.:_T..3±"u""p.N.it.-.HIT.pr.iF]EE..

Auditor'sReportonAnnualFlnancfalResultsofM/stsELta_Druf!s&lndust±It¥g

ifepursuanttotheRegulation33oftheSEBl|LlstlngObligationsandDisclosureRequirements) Regulations, 2015

TO,

The Board Of Directorslshlta Drugs & lndustrles Ltd

We have audited the statement of Annual financial results Of M/s lshlta I)rugs & Industrles Ltd for

the year ended 31S` March, 2018, attached herewith, being submitted by the company pursuant to

the requirement of Regulation 33 of the SEBI (ljstln8 Obligations and Disclosure Requlrements)

Regulations, 2015. These statement ls the responsibility Of the company's management and has

been approved by the Board Of Dlrectors. This statement has been prepared on the basis Of the

annual financial statements. Our responslbmty is to express an opinion on these financial results

based on our audlt of such annual financial statements, which have been prepared ln accordance

with the recognition and measurement principles lald down ln Accountln8 Standard for Interim

Financial Reporting (AS 25), prescribed, under Section 133 of the Companies Act, 2013 read with

relevantruleslssuedthereunderandotheraccountlngprinciplesgenerallyacceptedlnlndla.

We conducted our audlt ln accordance with the audltlng standards generally accepted in lndla.

Those standards require that we plan and perform the audit to obtain reasonable assurance about

whetherthefinancialresultsarefreeofmaterialmisstatement(s).Anauditlncludesexamlnlng,ona

test basis, evidence supporting the amounts dlsclosed as flnanclal results. An audit also includes

assessing the accounting prlnclples used and signlficant estlmates made by management.We believe

thatourauditprovidesareasonablebaslsforouroplnlon.

Inouropinlonandtothebestofourinformationandaccordlngtotheexplanationsgiventousthese

financial results:

(i) are presented ln accordance with the requirements ofRegulatlon 33 of the sEBl (ustlngObllgatlons and Disclosure Requlrements) Regulatlons, 2015 In thls regard; and

(ii) give a true and falr vlew of the net profit and other flnanclal information for the periodfrom Olst Aprll, 2017 to 31st March, 2018.

Thefinanclalresultsincludeth6resultsfortheQuarterendedMarch31,2018,beingthebalancing

figurebetweenauditedflgureslnrespectoffullflnanclalyearandthepubllshedyeartodateflgures

uptothethirdquarteroftheflnanclalyear,whlchweresubJecttollmltedrevlewbyus.

Date: 29/05/2018 For and on behalf of

MRN -180309

Place: Ahmedabad

B-&itll' Rajbaug Society, Canal Road,

` PRATI K RAuSHIKl(UMAR KIKAN I

Chartered Accountants

k`hafyJ fl4CA Pratlk I(aushlkkumar KlkanlM.NO.180309

Ghodasar, Ahemdabad -380050Telephone - 9687674839 / 966Z263926 Mail • klkanipratik@yahoo.co.In

lsHITA DRUGS & INDUSTRIES LTD.Corp. Off.: 401, 3rd Eye 11, Opp. Parimal Garden, C. G. Road, Ahmedabad-380006.Phone : +919228016100 -03 I +9179 2646 8353. 4002 3839 I Far : +9179 26404961Regd. Office & Factory : 179/I, Vasna-lyava, Tal. Sanand. Dist. : Ahmedabad.i-mail : info@ishitadrugs.com I ishitadrugs@vsnl.net I URL : www.ishitadrugs.com

Date: 29th May, 2018

To,The Company SectionThe Bombay Stock ExchangePhiroz Jij ibhoy TowersDDalalStreet,Bombay-400001

Dear Sir,

Ref: Ishita Druz!s and industries limited

Seciecuritvcode:524400

=:::#:=rE:#=]ng"#7#u:::sE#rtfroinDEFriedrithr==±±;g=:We hereby declare that we are hereby submitting the Audit Report in respect ofstandalone financial statement for the financial year 2017-18 along with the financialresults on 29th May, 2018. Pursuant to the requirement 33 (3) (d) of SEBI (ListingObligations and Disclosure Requirement) Regulation2015 we hereby declare that theauditors have expressed an unmodified opinion in their audit reports on standalonefinancialstatementofthecompanyfrothefinancialyear2017-18.

Thanking You.

"our6asicdrugsintheserviceOfhu:rrlwityiuorfuwide"

CIN No. L24231 GJ1992PLC017054D & 8 D-U-N-S Number -65-010-0359